English (United Kingdom)Thai (ภาษาไทย)

Tentative result for EQAI 2012

 
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 TRIAL 01-12-4 
 

Control material NO.

01-12-4-1

01-12-4-2

01-12-4-3

01-12-4-4

Non treponemal test

Non Reactive

Non Reactive

Reactive

Reactive

Treponemal test

NS

Reactive

Reactive

Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 TRIAL 02-12-4 
 

Control material NO.

02-12-4-1

02-12-4-2

02-12-4-3

02-12-4-4

HBsAg (S/CO)

NEGATIVE
0.26± 0.06 (CMIA)

POSITIVE
5397.43 ± 457.70(CMIA)

POSITIVE
1113.21 ± 144.8 (CMIA)

POSITIVE
1669.81 ± 314.57(CMIA)

antiHBs
(all methods)
(mIU/ml)

POSITIVE
54.92 ± 72.19

NEGATIVE
0.61 ± 0.83

NEGATIVE
0.83± 1.0

NEGATIVE
0.66±0.85

antiHBc

NEGATIVE

POSITIVE

POSITIVE

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

NEGATIVE

POSITIVE

POSITIVE

POSITIVE

 

 

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 TRIAL 01-12-3 
 

Control material NO.

01-12-3-1

01-12-3-2

01-12-3-3

01-12-3-4

Non treponemal test

Non Reactive

Non Reactive

Reactive

Reactive

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 TRIAL 02-12-3  
 

Control material NO.

02-12-3-1

02-12-3-2

02-12-3-3

02-12-3-4

HBsAg (S/CO)

POSITIVE
4681.5± 740.9 (CMIA)

POSITIVE
6632.3 ± 872.3(CMIA)

POSITIVE
371.8 ± 91.2 (CMIA)

NEGATIVE
0.3 ± 0.1  (CMIA)

antiHBs
(all methods)
(mIU/ml)

NEGATIVE
0.31 ± 0.61

NEGATIVE
0.3 ± 0.6

NEGATIVE
0.6± 0.8

NEGATIVE
0.7±1.2

antiHBc

POSITIVE

POSITIVE

POSITIVE

POSITIVE

HBeAg

POSITIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

NEGATIVE

POSITIVE

POSITIVE

POSITIVE

 

 

 

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 TRIAL 01-12-2 
 

Control material NO.

01-12-2-1

01-12-2-2

01-12-2-3

01-12-2-4

Non treponemal test

Reactive

Reactive

Non Reactive

Non Reactive

Treponemal test

Reactive

Reactive

Reactive

Non Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 TRIAL 02-12-2  
 

Control material NO.

02-12-2-1

02-12-2-2

02-12-2-3

02-12-2-4

HBsAg

POSITIVE
146.93± 23.07 (ECLIA)

NEGATIVE
0.59 ± 0.18(ECLIA)

NEGATIVE
0.61 ± 0.19 (ECLIA)

NEGATIVE
0.60 ± 1.83 (ECLIA)

antiHBs
(all methods)
mIU/ml

NEGATIVE
2.06 ± 0.99

POSITIVE
223.76 ± 57.33

POSITIVE
84.22± 34.47

POSITIVE
222.86±50.59

antiHBc

POSITIVE

POSITIVE

NEGATIVE

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

NEGATIVE

NS

NEGATIVE

 
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 TRIAL 01-12-1 
 

Control material NO.

01-12-1-1

01-12-1-2

01-12-1-3

01-12-1-4

Non treponemal test

Reactive

Reactive

Reactive

Reactive

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 TRIAL 02-12-1  
 

Control material NO.

02-12-1-1

02-12-1-2

02-12-1-3

02-12-1-4

HBsAg

POSITIVE
11,261.6± 839.3 (ECLIA)

POSITIVE
2,106.3 ± 243.3 (ECLIA)

NEGATIVE
0.7 ± 0.6 (ECLIA)

NEGATIVE
0.51 ± 0.25 (ECLIA)

antiHBs
(all methods)
mIU/ml

NEGATIVE
0.34 ± 0.60

NEGATIVE
0.43 ± 1.18

NS
25.8± 93.9

POSITIVE
871.44±251.59

antiHBc

POSITIVE

POSITIVE

NEGATIVE

POSITIVE

HBeAg

NS

POSITIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

NEGATIVE

NEGATIVE

NEGATIVE

 

Search

Copyright © 2010 Faculty of Medical Technology, Mahidol University. All Rights Reserved. Download Internet Explorer 8 Top